Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Cannabis Stock News: Beleave (CSE: BE) (OTC: BLEVF) Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational Updates

Announcing new product line, Compliance Brand, to join Flyte Classic vape pens in Cannabis 2.0 product line, The Company has $2.7 Million in orders for Cannabis 2.0 products, which will ship in early 2020


Toronto, Ontario - December 19, 2019 (Newsfile Corp.) ( Newswire) Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to provide the following updates on its operations.

Compliance Brand Topicals

Beleave is excited to announce the launch of Compliance Brand, a new line of recreational cannabis-infused topical products, and the second initiative from Beleave and Volero Brands Inc.'s ("Volero") joint venture (the "Joint Venture" or "Partnership") after Flyte Classic vape pens. Announced on October 2019, the Partnership was formed to develop, produce, and distribute cannabis extracts, topicals, and edibles for the Canadian adult-use market.

Compliance Brands will launch with three products:

  • THC-Infused Face Serum
    An exceptionally light oil-based face serum that absorbs almost instantly into skin. This oil blend, high in linoleic acids, will not leave a greasy feeling on your skin. Contains jojoba seed, rosehip and lavender oils with a hemp seed ester and vitamin E.
  • THC-Infused Bath Oil
    All you need is a gentle stir to mix this product into your bath right away without slicks or residues. Contains hemp seed, birch bark, eucalyptus, marjoram, black pepper and nutmeg oils.
  • THC-Infused Multi-Use Balm
    This multi-purpose balm was created for every skin. Can be applied to lips, elbows, knees, heels or anywhere else that needs help and hydration. Contains coconut, apricot, hemp seed, jojoba, peppermint, rosemary and lavender oils with vitamin E.

Purchase Orders and Cannabis 2.0 Sales

This week, Beleave received the largest purchase order from a province in the Company’s history. The Company now has $2.7 Million in orders, which will ship in early 2020, for Cannabis 2.0 products.

Additional Employment Positions

Beleave's Human Resources team is seeking applications for seven new employment positions within the Company to bolster its workforce to assist with expanded operations in the coming months. Available positions will be posted publicly as needed.

Lloydminster, Saskatchewan Retail Store Update

As previously announced, the Company has finalized the sale of its retail location in Lloydminster, Saskatchewan and met all the criteria for the transfer of the license to the purchaser. The Company is now awaiting the SLGA's transfer of the license for the transaction to be completed, which it expects in the very near future.

London, Ontario Facility Update

With 250,000 sq ft of greenhouse space and 85 acres of land, the London, Ontario facility has received tremendous interest since it was placed on the market earlier this year. The Company looks forward to providing additional updates once an agreement has been finalized.


Beleave is an ISO certified, Canadian cannabis company headquartered in the Greater Toronto Area that cultivates high-quality cannabis flower, oil and extracts for medical and recreational markets. Beleave is fully licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives.

Beleave is developing new product lines, including cannabis-infused products, oils, vape pens, and other novel cannabis delivery methods for 2019. Beleave has developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.

Investor Relations Contact:

Kevin Keagan
Chief Executive Officer
Phone: 1 (647) 449 - 7352

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories for Cannabis stocks and Psychedelic Stocks

Buy a cannabis guest post on